CannaLean For Profit

Cannalean Biotechs is a company based in Israel that focuses on the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan for patients suffering from dyslipidemia. Dyslipidemia is a common condition where one or more serum lipid levels are abnormal. The company's pre-clinical in vivo results in Guinea pig and rat models show the effect of the novel formulation on cholesterol and triglycerides reduction. Cannalean Biotechs Ltd. was established in partnership with 'Mor Research Applications', the technology transfer unit of the largest HMO in Israel - ‘CLALIT’ Health Services (CHS). Contact info: 14-18 Baruch Hirsh, Bnei Brak, 5120206, Israel, Tel: (972) 3 617 6644, Fax: (972) 3 617 6647, E-mail: mail@cannaleanbio.com.

Founded Date: 2017-01-01
Headquarters: Bene Beraq, Tel Aviv, Israel
Technology: Biomarker panels
Industry: Clinical Data Management